Berkshire Hathaway Reduces Stake in DaVita Healthcare

Conglomerate sells 1.6 million shares of dialysis provider in Q3 2025

Mar. 15, 2026 at 9:08am

Got story updates? Submit your updates here. ›

Berkshire Hathaway Inc., the conglomerate led by billionaire Warren Buffett, reduced its stake in DaVita Inc. (NYSE: DVA) by 4.8% in the third quarter of 2025, according to a recent 13F filing with the SEC. Berkshire Hathaway sold 1,635,962 shares of the dialysis services provider, leaving it with a 32,160,579 share position, or approximately 45.55% ownership in the company.

Why it matters

DaVita is one of Berkshire Hathaway's largest holdings, so any changes to its position in the company are closely watched by investors. The reduced stake could signal a shift in Buffett's investment strategy or a belief that DaVita's growth prospects have diminished.

The details

According to the 13F filing, Berkshire Hathaway's position in DaVita was worth $4.27 billion as of the end of the third quarter. The conglomerate remains the largest shareholder of the dialysis provider, owning nearly half of the company's outstanding shares.

  • Berkshire Hathaway reduced its DaVita stake in the third quarter of 2025.

The players

Berkshire Hathaway Inc.

A multinational conglomerate holding company headquartered in Omaha, Nebraska, led by renowned investor Warren Buffett.

DaVita Inc.

A leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease.

Got photos? Submit your photos here. ›

The takeaway

Berkshire Hathaway's reduced stake in DaVita could signal a shift in the conglomerate's investment strategy or a belief that the dialysis provider's growth prospects have diminished. Investors will be closely watching to see if Buffett and his team make any further adjustments to their DaVita position in the coming quarters.